Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

SPDR® S&P Biotech ETF (XBI)

Delayed Data
As of Jul 21
 +0.63 / +0.79%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.


1 month+2.87% 3 years+20.82%
3 months+19.02% 5 years+22.10%
1 year+37.60% Since inception+15.26%
Data through 07/22/2017

Quote Details

Previous close$80.14
Open day’s range80.00 – 81.08
Net asset value (NAV)80.75 (07/21/2017)
Daily volume3,230,207
Average volume (3 months)4,233,326
Data as of 7:59pm ET, 07/21/2017

Peer Comparisonvs. Health ETFs

Performance 5-yr return+22.10%+17.39%
Expense Gross exp ratio0.35%1.33%
Risk 5 year sharpe ratio0.791.14
Net assets$3.5B$3.0B
Average market cap$4.6B$30.8B
Average P/E--24.5
Dividend / Share--0.30%


XLV Health Care Select Sector SPDR® Fund
RYH Guggenheim S&P 500® Equal Weight Health...
FHLC Fidelity® MSCI Health Care Index ETF


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
CLVS Clovis Oncology Inc2.96%
EXEL Exelixis Inc2.44%
KITE Kite Pharma Inc2.26%
ALXN Alexion Pharmaceuticals Inc2.21%
CELG Celgene2.10%
ALNY Alnylam Pharmaceuticals Inc2.09%
GILD Gilead Sciences2.09%
SRPT Sarepta Therapeutics Inc2.05%
EXAS Exact Sciences Corp2.02%
INCY Incyte Corp2.02%